COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT03072160
Brief Title: Pembrolizumab in Recurrent or Metastatic Medullary Thyroid Cancer

First Submitted : March 3, 2017
First Submitted that Met QC Criteria : March 3, 2017
First Posted : March 7, 2017

Last Update Submitted that Met QC Criteria : June 5, 2020
Last Update Posted : June 9, 2020